The Discounted Cash Flow (DCF) valuation of China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS) is 18.93 CNY. With the latest stock price at 19.20 CNY, the upside of China Resources Double-Crane Pharmaceutical Co Ltd based on DCF is -1.4%.
Based on the latest price of 19.20 CNY and our DCF valuation, China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS) is a sell. selling 600062.SS stocks now will result in a potential gain of 1.4%.
| Range | Selected | |
| WACC / Discount Rate | 8.1% - 11.3% | 9.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 14.97 - 26.95 | 18.93 |
| Upside | -22.1% - 40.3% | -1.4% |